Lidamycin decreases CD133 expression in hepatocellular carcinoma via the Notch signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lidamycin decreases CD133 expression in hepatocellular carcinoma via the Notch signaling pathway

Published:2017-10-20 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Chen Yi¹,Sun Wenwei¹,He Ran¹,Zhang Feiyan¹,Wang Hongyu¹,Li Panhong¹,Shao Rong‑Guang²,Xu Xiaoyu¹

Affiliation:

1. College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, P.R. China

2. Laboratory of Oncology, Ministry of Health Key Laboratory of Antibiotic Bioengineering, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody MYH9 and Antibiotic Lidamycin Inhibit the Growth and Proliferation of Lung Cancer Cells and Induce Their Apoptosis;Molecular Biotechnology;2024-07-13

2. Unravelling the Mysteries of the Sonic Hedgehog Pathway in Cancer Stem Cells: Activity, Crosstalk and Regulation;Current Issues in Molecular Biology;2024-05-29

3. The Intricate Notch Signaling Dynamics in Therapeutic Realms of Cancer;ACS Pharmacology & Translational Science;2023-05-03

4. New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation;Journal of Cellular Physiology;2019-05-17

5. The Carcinogenic Role of the Notch Signaling Pathway in the Development of Hepatocellular Carcinoma;Journal of Cancer;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP